H&E staining of tumor sections showed that combined KHSRP knockdown and carboplatin treatment markedly increased tumor necrotic areas compared to either sh-KHSRP-2 or NC + carboplatin treatment groups (Fig. 5D). This evidence concerns the gene KHSRP and neoplasm.